相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic Exon Skipping Through a CRISPR-Guided Cytidine Deaminase Rescues Dystrophic Cardiomyopathy in Vivo
Jia Li et al.
CIRCULATION (2021)
Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy
Sophia E. Silver et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Cardiac organoid - a promising perspective of preclinical model
Dandan Zhao et al.
STEM CELL RESEARCH & THERAPY (2021)
Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing
F. Chemello et al.
SCIENCE ADVANCES (2021)
In vivo somatic cell base editing and prime editing
Gregory A. Newby et al.
MOLECULAR THERAPY (2021)
Efficient precise in vivo base editing in adult dystrophic mice
Li Xu et al.
NATURE COMMUNICATIONS (2021)
Intramyocardial Transplantation of Human iPS Cell-Derived Cardiac Spheroids Improves Cardiac Function in Heart Failure Animals
Shinji Kawaguchi et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)
Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis
Erik Landfeldt et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)
The 10th Oligonucleotide Therapy Approved: Golodirsen for Duchenne Muscular Dystrophy
Annemieke Aartsma-Rus et al.
NUCLEIC ACID THERAPEUTICS (2020)
Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery
Arun Sharma et al.
CELL STEM CELL (2020)
Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants
Russell T. Walton et al.
SCIENCE (2020)
BEON: A Functional Fluorescence Reporter for Quantification and Enrichment of Adenine Base-Editing Activity
Peipei Wang et al.
MOLECULAR THERAPY (2020)
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
Michelle F. Richter et al.
NATURE BIOTECHNOLOGY (2020)
Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity
Dylan J. Richards et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
Christopher E. Nelson et al.
NATURE MEDICINE (2019)
Life-Long AAV-Mediated CRISPR Genome Editing in Dystrophic Heart Improves Cardiomyopathy without Causing Serious Lesions in mdx Mice
Li Xu et al.
MOLECULAR THERAPY (2019)
Evaluation of commonly used ectoderm markers in iPSC trilineage differentiation
Yu-Lin Kuang et al.
STEM CELL RESEARCH (2019)
Targeted exon skipping with AAV-mediated split adenine base editors (vol 5, 41, 2019)
Jackson Winter et al.
CELL DISCOVERY (2019)
Genome-wide profiling of adenine base editor specificity by EndoV-seq
Puping Liang et al.
NATURE COMMUNICATIONS (2019)
A Python Program to Quantify Base Editing from Sanger Sequencing
Li Xu et al.
CRISPR JOURNAL (2019)
Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements
Michael Kosicki et al.
NATURE BIOTECHNOLOGY (2018)
Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction
Luke W. Koblan et al.
NATURE BIOTECHNOLOGY (2018)
p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells
Robert J. Ihry et al.
NATURE MEDICINE (2018)
CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response
Emma Haapaniemi et al.
NATURE MEDICINE (2018)
Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing
Chengzu Long et al.
SCIENCE ADVANCES (2018)
CRISPR-Induced Deletion with SaCas9 Restores Dystrophin Expression in Dystrophic Models In Vitro and In Vivo
Benjamin L. Duchene et al.
MOLECULAR THERAPY (2018)
Large deletions induced by Cas9 cleavage
Fatwa Adikusuma et al.
NATURE (2018)
Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy
Leonela Amoasii et al.
SCIENCE (2018)
Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase
Juanjuan Yuan et al.
MOLECULAR CELL (2018)
Respiratory Management of the Patient With Duchenne Muscular Dystrophy
Daniel W. Sheehan et al.
PEDIATRICS (2018)
Targeting fidelity of adenine and cytosine base editors in mouse embryos
Hye Kyung Lee et al.
NATURE COMMUNICATIONS (2018)
CRISPR-SKIP: programmable gene splicing with single base editors
Michael Gapinske et al.
GENOME BIOLOGY (2018)
Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges
Yusuke Echigoya et al.
JOURNAL OF PERSONALIZED MEDICINE (2018)
AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice
Chady H. Hakim et al.
JCI INSIGHT (2018)
Exon skipping: a first in class strategy for Duchenne muscular dystrophy
Erik H. Niks et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage
Nicole M. Gaudelli et al.
NATURE (2017)
Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs
Ming-Tao Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy
Niclas E. Bengtsson et al.
NATURE COMMUNICATIONS (2017)
CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome
Ha Youn Shin et al.
NATURE COMMUNICATIONS (2017)
CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice
Yu Zhang et al.
SCIENCE ADVANCES (2017)
Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction
Sebastian V. Rojas et al.
PLOS ONE (2017)
In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice
Mona El Refaey et al.
CIRCULATION RESEARCH (2017)
Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
Chengzu Long et al.
SCIENCE (2016)
In vivo gene editing in dystrophic mouse muscle and muscle stem cells
Mohammadsharif Tabebordbar et al.
SCIENCE (2016)
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
Christopher E. Nelson et al.
SCIENCE (2016)
A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells
Courtney S. Young et al.
CELL STEM CELL (2016)
The importance of genetic diagnosis for Duchenne muscular dystrophy
Annemieke Aartsma-Rus et al.
JOURNAL OF MEDICAL GENETICS (2016)
CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice
Li Xu et al.
MOLECULAR THERAPY (2016)
Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts
Yuji Shiba et al.
NATURE (2016)
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Alexis C. Komor et al.
NATURE (2016)
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
Keiji Nishida et al.
SCIENCE (2016)
Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method
Jean-Paul Iyombe-Engembe et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse
Caroline Godfrey et al.
HUMAN MOLECULAR GENETICS (2015)
The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
Catherine L. Bladen et al.
HUMAN MUTATION (2015)
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy
David G. Ousterout et al.
NATURE COMMUNICATIONS (2015)
Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
Hongmei Lisa Li et al.
STEM CELL REPORTS (2015)
Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases
Sangsu Bae et al.
BIOINFORMATICS (2014)
Engineering Adolescence Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes
Xiulan Yang et al.
CIRCULATION RESEARCH (2014)
Chemically defined generation of human cardiomyocytes
Paul W. Burridge et al.
NATURE METHODS (2014)
Skipping Multiple Exons of Dystrophin Transcripts Using Cocktail Antisense Oligonucleotides
Yusuke Echigoya et al.
NUCLEIC ACID THERAPEUTICS (2014)
Eteplirsen for the Treatment of Duchenne Muscular Dystrophy
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2013)
Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions
Xiaojun Lian et al.
NATURE PROTOCOLS (2013)
Restoring Dystrophin Expression in Duchenne Muscular Dystrophy Muscle Progress in Exon Skipping and Stop Codon Read Through
Eric P. Hoffman et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak et al.
LANCET (2011)
Duchenne muscular dystrophy: Survival by cardio-respiratory interventions
Yuka Ishikawa et al.
NEUROMUSCULAR DISORDERS (2011)
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Nathalie M. Goemans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics
Abdallah Fayssoil et al.
HEART FAILURE REVIEWS (2010)
Design of Phosphorodiamidate Morpholino Oligomers ( PMOs) for the Induction of Exon Skipping of the Human DMD Gene
Linda J. Popplewell et al.
MOLECULAR THERAPY (2009)
Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice
Haifang Yin et al.
MOLECULAR THERAPY (2008)
Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63 % of patients with Duchenne muscular dystrophy
Christophe Beroud et al.
HUMAN MUTATION (2007)
Pathophysiology of duchenne muscular dystrophy: Current hypotheses
Nicolas Deconinck et al.
PEDIATRIC NEUROLOGY (2007)
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD
G. McClorey et al.
GENE THERAPY (2006)
Targeted exon skipping in transgenic hDMD mice:: A model for direct preclinical screening of human-specific antisense oligonucleotides
M Bremmer-Bout et al.
MOLECULAR THERAPY (2004)
Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells
JCT van Deutekom et al.
HUMAN MOLECULAR GENETICS (2001)
分享论文
